The Walton family fortune grew astoundingly in the past year — to the tune of $23 billion. Photo via Getty Images

It's hardly a surprise that America's Walton family, including Fort Worth billionaire Alice Walton, remains the world's richest family. What's truly stunning is how much their wealth has grown in the past year — by more than $23 billion.

In once again crowning the Waltons the world's richest family, the Bloomberg news service recently reported that their collective fortune had risen by $23 billion in the past year due to the climbing stock price of the Walmart retail chain. Sam Walton opened the first Walmart store in 1962.

Descendants of Sam and his brother, Bud, control more than 1.3 billion shares of Walmart stock either directly or through family trusts, Bloomberg says. Even though the Waltons have liquidated $6 billion in Walmart stock this year, they're now worth more in 2021 than they were in 2020.

As of mid-September, the Waltons were worth $238.2 billion, according to Bloomberg. That's almost $100 billion above the next richest family in the world, the Mars family of candy and pet care fame. Last year, Bloomberg pegged the Waltons' fortune at $215 billion.

To put the Waltons' one-year, $23 billion bump in wealth into perspective, Bloomberg estimates the net worth of Walmart heir Lukas Walton at $22 billion.

Alice Walton ranks as the second richest person in Texas (No. 1 is Elon Musk, at more than $200 billion), but she's not the richest Walmart heir. As of September 27, Bloomberg estimated Walton's net worth at $61.9 billion, making her the 19th richest person in the world. Ahead of her are brothers Jim ($63.7 billion, No. 17 worldwide) and Rob ($63.3 billion, No. 18 worldwide).

Not everyone is impressed with the Waltons' mountain of money. In February, U.S. Sen. Bernie Sanders, an independent from Vermont, branded the Waltons "the poster child for greed," based on the retailer's low starting wage. Walmart recently raised its minimum pay for hourly workers from $11 to $12.

"This is a family that is incredibly wealthy," Sanders said of the Waltons before the wage increase took effect.

"One of their owners spend[s] zillions of dollars on antique cars. They've got mansions. They have all kinds of art collections," the senator told CNN. "But somehow or another they can't pay their starting wage at more than 11 bucks an hour."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.